Merit Medical Systems (MMSI) Cost of Revenue (2010 - 2026)

Merit Medical Systems has reported Cost of Revenue for 17 years, with the latest figure at $203.7 million in Q2 2026.

• Quarterly Cost of Revenue rose 2.88% year-over-year to $203.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $797.1 million (up 6.88% YoY) and the FY2025 annual result came in at $777.6 million, up 9.04% from the prior year.
• Cost of Revenue improved to $203.7 million in Q2 2026 per MMSI's latest filing, from $197.1 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $203.7 million in Q2 2026 and troughed at $154.5 million in Q1 2022.
• A 5-year average of $177.6 million and a median of $175.4 million in 2023 frame the typical range for Cost of Revenue.
• The widest YoY moves for Cost of Revenue: up 12.76% in 2022, down 2.38% in 2022.
• Over 5 years, Cost of Revenue stood at $158.9 million in 2022, then gained by 9.52% to $174.0 million in 2023, then advanced by 4.71% to $182.2 million in 2024, then advanced by 9.01% to $198.6 million in 2025, then increased by 2.56% to $203.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $203.7 million, $197.1 million, and $198.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.